4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Sera Prognostics, Inc. (SERA) operates in the Medical Devices industry and is headquartered in Salt Lake City, United States with about 71 employees. Its market capitalization is roughly $81 million. In the fiscal year ended 2025-12-31, SERA reported $0M in revenue and ($32M) in net income.
Sera Prognostics, Inc., a women's health company, discovers, develops, and commercializes blood-based biomarker tests, and predictive analytic products and services in the United States.
Interactive charts & full statements → Open the SERA valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | — |
| Gross Profit | ($0M) | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($36M) | ($37M) | ($40M) | ($46M) | — |
| Net Income | ($32M) | ($33M) | ($36M) | ($44M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M |
| Gross Profit | $0M | $0M | $0M | $0M | $0M |
| Operating Income (EBIT) | ($9M) | ($9M) | ($9M) | ($9M) | ($9M) |
| Net Income | ($8M) | ($8M) | ($8M) | ($8M) | ($8M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $102M | $73M | $95M | $116M | — |
| Total Liabilities | $26M | $25M | $25M | $17M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive SERA viewer.
About TickerBase · Data methodology & sources